AMA & Health2047: Warren Templeton on Transforming Healthcare Through Venture Innovation
Recorded live at HLTH, this episode of Bright Spots in Healthcare takes you inside Health2047, the venture studio founded by the American Medical Association to tackle some of healthcare’s gnarliest problems. Host Eric Glazer sits down with Warren Templeton, Managing Director at Health2047, to explore how the AMA is backing founders at the earliest stages to reshape physician workflows, chronic disease management, and data liquidity.
Warren shares how Health2047 partners with science- and clinician-led startups at the pre-seed and seed stages, wrapping founders with commercial strategy, clinical and billing expertise, and an evergreen capital model that matches healthcare’s longer time horizons. He also unpacks why humility and conviction are the two non-negotiable traits he looks for in founders.
You’ll hear real-world examples from Health2047’s portfolio, including:
- Zing Health – a Medicare Advantage plan built for underserved communities, rooted in social determinants of health and community-based design
- Phenomics Health – an obesity phenotyping company born from a “failed” diabetes prevention bet, now helping match patients to the right GLP-1s, procedures, and care pathways
- ScholarRx – a global medical education platform partnering with the WHO to enable high-quality “tertiary care in the wild” for clinicians around the world
Warren and Eric also dig into:
- Why traditional 5–7 year VC timelines often clash with healthcare reality
- How to balance breakthrough science with practical workflow integration and commercial viability
- The impact KPIs Health2047 tracks beyond IRR, including lives and care teams impacted
If you’re a founder, investor, or healthcare leader trying to build something that actually works in the real world—not just on a pitch deck—this conversation offers a candid look at what it takes to design, fund, and scale the next generation of healthcare companies.
